Mapp Biopharmaceutical (United States)

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

Xiangguo Qiu, Gary Wong, Jonathan Audet et al. · Nature · 2014 · 976 citations · Full text

Emerging Infectious Diseases, Viral Pathogenesis, Emergent Virus +5

Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques

Gene G. Olinger, James Pettitt, Do Hyoung Kim et al. · Proceedings of the National Academy of Sciences · 2012 · 369 citations · Full text

Cutting Edge: The Mucosal Adjuvant Cholera Toxin Redirects Vaccine Proteins into Olfactory Tissues

Frederik W. van Ginkel, Raymond J. Jackson, Yoshikazu Yuki et al. · The Journal of Immunology · 2000 · 362 citations

Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant

Larry Zeitlin, James Pettitt, Corinne Scully et al. · Proceedings of the National Academy of Sciences · 2011 · 228 citations

Immunodeficiencies, Immunology, Immunodominance +20

Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection

Erica Ollmann Saphire, Sharon L. Schendel, Marnie L. Fusco et al. · Cell · 2018 · 224 citations · Full text

Vaccination, Virus Epidemiology, Vaccine Target +7